logo
Select company
Select metric
-3321.76%EBIT Margin
VS
Market
3
Sector
12
Industry
21
History
50
$ 3.65Close
$ 2.67 - $ 527 52-Week Range
Ticker Information

Ticker

ONCO

Company Name

ONCONETIX INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ONCONETIX INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ONCO - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -44.08M-3321.76%$ 1.33M
3/31/2025$ -55.82M-2899.46%$ 1.93M
12/31/2024$ -58.33M-2310.85%$ 2.52M
9/30/2024$ -50.4M-2694.07%$ 1.87M
6/30/2024$ -51.97M-3550.78%$ 1.46M
3/31/2024$ -44.73M-5894.22%$ 758.9K
12/31/2023$ -36.75M-62859.25%$ 58.47K
9/30/2023$ -17.79M0%$ 0
6/30/2023$ -16.58M0%$ 0
3/31/2023$ -14.2M0%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ONCONETIX INC's latest trailing twelve months (TTM) EBIT % stands at 0%.
  • Over the past 5 years, ONCONETIX INC's average EBIT % has been -11932.91%.
  • The median EBIT % for ONCONETIX INC during this period was -3321.76%
  • ONCONETIX INC reached its highest EBIT % over the past 5 years at -2310.85%.
  • The lowest EBIT % recorded by ONCONETIX INC in the same timeframe -62859.25%

ONCONETIX INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
SPRB : SPRUCE BIOSCIENCES INC -3549.11%SXTP : 60 DEGREES PHARMACEUTICALS INC -918.16%VIVS : VIVOSIM LABS INC -1389.44%XBIO : XENETIC BIOSCIENCES INC -126.03%OGEN : ORAGENICS INC -GLTO : GALECTO INC -ADTX : ADITXT INC -250836.49%CDT : CONDUIT PHARMACEUTICALS INC -GTBP : GT BIOPHARMA INC -DRMA : DERMATA THERAPEUTICS INC -

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for ONCONETIX INC is calculated as follows: EBIT [ $ -3.42M ] / Revenues [ $ 0 ]
(=) EBIT % [ 0% ]

ONCO - EBIT Margin, Last 5 years

-62859.25%

Minimum

Dec 31, 2023

-2310.85%

Maximum

Dec 31, 2024

-11932.91%

Average

-3321.76%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.55% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.55%
median9.01%
std23.96%